Citigroup’s Sonoma Pharmaceuticals SNOA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.04K Buy
+1,425
New +$4.17K ﹤0.01% 5363
2025
Q4
Sell
-656
Closed -$2.54K 6434
2025
Q3
$2.54K Buy
+656
New +$2.58K ﹤0.01% 5421
2025
Q2
Sell
-811
Closed -$1.78K 5892
2025
Q1
$1.78K Buy
+811
New +$2.19K ﹤0.01% 5347
2024
Q4
Sell
-180
Closed -$553 5949
2024
Q3
$553 Buy
+180
New +$919 ﹤0.01% 5477
2018
Q2
Hold
0
7728
2018
Q1
Hold
0
7665
2017
Q4
Hold
0
7643
2017
Q3
Hold
0
7424
2017
Q2
Hold
0
7465
2017
Q1
Hold
0
7326
2016
Q4
Hold
0
7318
2016
Q3
Hold
0
7188
2016
Q2
Hold
0
7404
2016
Q1
Sell
-1
Closed -$929 7735
2015
Q4
$0 Buy
+1
New +$1.07K ﹤0.01% 7839
2015
Q3
Sell
-2
Closed -$2.37K 7685
2015
Q2
$3K Buy
+2
New +$1.87K ﹤0.01% 7015
2015
Q1
Sell
-1
Closed -$850 7406
2014
Q4
$1K Buy
+1
New +$1.56K ﹤0.01% 6990
2014
Q3
Hold
0
7281
2014
Q2
Hold
0
6948
2014
Q1
Hold
0
6890
2013
Q4
Hold
0
6876
2013
Q3
Hold
0
6962
2013
Q2
Hold
0
6790

Other funds holding SNOA

Citigroup's SNOA Position: Q1 2026 in Review

Citigroup opened a new position in Sonoma Pharmaceuticals (SNOA) in Q1 2026: 1,425 shares worth $3.04K. The stake represents ﹤0.01% of the portfolio and ranks #5363 among its holdings. This is a return to the name: Citigroup previously reported a position in SNOA as recently as Q3 2025.

Citigroup first reported a position in SNOA in Q4 2014 and has held it in 7 quarters since. 17 funds tracked by Wall St. Rank hold SNOA as of Q1 2026.

  • Citigroup held 1,425 shares of Sonoma Pharmaceuticals worth $3.04K as of Q1 2026.
  • Sonoma Pharmaceuticals was a new Citigroup position in Q1 2026.
  • Sonoma Pharmaceuticals made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #5363 holding.
  • Citigroup first reported a position in Sonoma Pharmaceuticals in Q4 2014 and has held it in 7 quarters since.
  • 17 funds tracked by Wall St. Rank held Sonoma Pharmaceuticals as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.